Colossal Biosciences’ $150M Series B Financing

Martina Bellini
Tagged:

Gunderson Dettmer represented Colossal Biosciences on the deal.Colossal Biosciences, a genetic engineering company, announced its $150 million Series B financing led by United States Innovative Technology Fund….

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

…

This content is for Standard 1 Year members only.
Login Join Now